1-[3,5-Bis(trifluoromethyl)phenyl]pyrrole, 97.0%, 5g

GC capillary column ROTI®Cap-1701, 50 m, 0.32 mm, 0.50 µm, 1 Piece(s)

5'-Bromo-2',3'-dihydrospiro[imidazolidine-4,1'-indene]-2,5-dione, 97%, 500mg

N-1H-1,2,4-triazol-3-ylacetamide, 95.0%, 5g

3-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOLE-5-CARBONITRILE, 95.0%, 250mg

ethyl 1-ethylcyclobutane-1-carboxylate, 97.0%, 1g

4-([1,1'-Biphenyl]-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine, 97%, 5g

2-(3-Chloro-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

2-(Cyanomethyl)benzimidazole, 98.0%, 1g

ethyl 5-chloro-5-oxopentanoate, 98.0%, 5g

PERINDOPRIL ERBUMINE, 95%, 1g

5-Bromo-2-chloroquinazolin-4-amine, 95.0%, 250mg

5-TERT-BUTYL 3-ETHYL 4H,5H,6H,7H-[1,2]OXAZOLO[4,5-C]PYRIDINE-3,5-DICARBOXYLATE, 95.0%, 2g